Avoiding leukocyte contamination and early platelet activation in platelet-rich plasma.

dc.contributor.authorTrindade-Suedam, Ivy K
dc.contributor.authorLeite, Fábio R M
dc.contributor.authorde Morais, Juliana A N D
dc.contributor.authorLeite, Elza R M
dc.contributor.authorMarcantonio, Elcio Júnior
dc.contributor.authorLeite, Amauri A
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:22:40Z
dc.date.available2014-05-27T11:22:40Z
dc.date.issued2007-12-01
dc.description.abstractThe objective of this study was to describe a new platelet-rich plasma (PRP) protocol with a reduced concentration of leukocytes and intact platelets. We collected 8 mL of venous blood (VB) from marginal ear veins of 10 male New Zealand white rabbits in acid dextrose citrate Vacutainer tubes. Tubes were centrifuged at 302g for 10 minutes. All plasma was collected in plastic tubes to avoid buffy-coat contamination and centrifuged at 2862g for 5 minutes. A 10% calcium chloride activator (10 PRP:2 CaCl2) was added to the lower third of this plasma (PRP), and the PRP gel was obtained. Mean platelet count was 317.7 x 10(3) +/- 39.9/microL in VB and 1344.9 x 10(3) +/- 347.5/microL in PRP. Leukocyte counts were 3.96 x 10(3) +/- 2.01/microL and 0.46 x 10(3) +/- 0.45/microL in VB and PRP, respectively. Mean platelet enrichment was 327.4 +/- 97.8%. All differences were statistically significant (P > .05). This protocol is practical and reproducible, resulting in a high concentration of intact platelets to help tissue repair and low levels of leukocytes.en
dc.format.extent334-339
dc.identifierhttp://dx.doi.org/10.1563/1548-1336(2007)33[334:ALCAEP]2.0.CO;2
dc.identifier.citationThe Journal of oral implantology, v. 33, n. 6, p. 334-339, 2007.
dc.identifier.doi10.1563/1548-1336(2007)33[334:ALCAEP]2.0.CO;2
dc.identifier.issn0160-6972
dc.identifier.scopus2-s2.0-79958257989
dc.identifier.urihttp://hdl.handle.net/11449/70045
dc.language.isoeng
dc.relation.ispartofThe Journal of oral implantology
dc.relation.ispartofjcr1.212
dc.relation.ispartofsjr0,569
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectanimal
dc.subjectcentrifugation
dc.subjectcytology
dc.subjectleukocyte
dc.subjectleukocyte count
dc.subjectmale
dc.subjectphysiology
dc.subjectplasmapheresis
dc.subjectrabbit
dc.subjectthrombocyte
dc.subjectthrombocyte activation
dc.subjectthrombocyte count
dc.subjectthrombocyte rich plasma
dc.subjectAnimals
dc.subjectBlood Platelets
dc.subjectCentrifugation
dc.subjectLeukocyte Count
dc.subjectLeukocytes
dc.subjectMale
dc.subjectPlasmapheresis
dc.subjectPlatelet Activation
dc.subjectPlatelet Count
dc.subjectPlatelet-Rich Plasma
dc.subjectRabbits
dc.titleAvoiding leukocyte contamination and early platelet activation in platelet-rich plasma.en
dc.typeArtigo
dcterms.licensehttp://www.joionline.org/userimages/ContentEditor/1240858717108/Terms_and_Conditions_ORIM1.pdf
unesp.author.orcid0000-0002-9660-4524[5]

Arquivos

Coleções